Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03041181
Title Docetaxel Plus Nivolumab or Docetaxel Alone in Patients With Advanced Non-squamous NSCLC Previously Treated With Nivolumab
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nasser Hanna, M.D.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
St. Vincent Anderson Regional Hospital Anderson Indiana 46016 United States Details
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
IU Health Central Indiana Cancer Center Indianapolis Indiana 46219 United States Details
Community Regional Cancer Care Indianapolis Indiana 46256 United States Details
IU Health Ball Memorial Hospital Cancer Center Muncie Indiana 47303 United States Details
Community Healthcare System Munster Indiana 46321 United States Details
HealthPartners Institute Minneapolis Minnesota 55440 United States Details
University of Texas Medical Branch at Galveston Galveston Texas 77555 United States Details
University of Virginia Health System Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field